Determining the frequency of germline and somatic mechanisms inactivating MLH1 in sebaceous neoplasms will improve triaging approaches for Lynch syndrome that avoid unnecessary testing and diagnostic delays in people with sebaceous neoplasms. The gene discussed is MLH1; the disease is sebaceous gland neoplasm.